Navigation Links
Pharmasset Reports Fiscal Year End 2011 Financial Results
Date:11/14/2011

cause our actual results to differ from those contained in the forward-looking statements, see the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended September 30, 2011 and our Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission and discussions of potential risks, uncertainties, and other important factors in our subsequent filings with the Securities and Exchange Commission.

PHARMASSET, INC. STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS(in thousands, except share and per share amounts)Years Ended September 30,201120102009Revenues

$
897$
,020$
3,293COSTS AND EXPENSES:  Research and development

75,85048,26152,552  General and administrative

16,65116,45813,365Total costs and expenses

92,50164,71965,917Operating loss

(91,604)(63,699)(52,624)Investment income

158221Other income

489--Interest expense

(1,058)(2,391)(3,190)Loss before income taxes

(92,158)(66,082)(55,593)Provision (benefit) for income taxes

(973)--Net loss

$
(91,185)$
(66,082)$
(55,593)COMPREHENSIVE LOSS:  Net loss

$
(91,185)$
(66,082)$
(55,593)  Unrealized gain on available-for-sale investments

--3Comprehensive loss

$
(91,185)$
(66,082)$
(55,590)NET LOSS PER SHARE:  Basic and diluted

$
(1.25)$
(1.07)$
(1.05)WEIGHTED AVERAGE SHARES OUTSTANDING:  Basic and diluted

72,776,98161,909,96652,959,064PHARMASSET, INC.BALANCE SHEETS(in thousands, except par value, share and per share amounts)As of September 30,20112010ASSETSCURRENT ASSETS:  Cash and cash equivalents

$ 166,455$ 127,081  Amounts due from collaboration partner

-6  Prepaid expenses and other assets

3,528718Total current assets

169,983127,805EQUIPMENT AND LEASEHOLD IMPROVEMENTS:  Equipment

4,8114,060  Leasehold improvements'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
2. Pharmasset to Present at the Upcoming Citibank and Morgan Stanley Investor Conferences
3. Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders
4. Pharmasset to Present at the JMP Securities Healthcare Focus Conference on Monday, October 6th
5. Pharmasset to Present at the Natixis Bleichroeder Hidden Gems Conference on Monday, October 13th
6. Pharmasset to Present at Two Upcoming Investor Conferences
7. Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients
8. Pharmasset Announces $45.5 Million Registered Direct Offering of Common Stock
9. Pharmasset Reports Fiscal First Quarter 2009 Financial Results
10. InterMune and Pharmasset to Discuss INFORM-1 Results From EASL Conference, April 25
11. Pharmasset Reports Fiscal Second Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... ATCC, the premier global biological materials ... important appointments to the senior leadership team. Barbie Bigelow ... and Technology and Dr. Maryellen de Mars also joins ... Both roles are new positions at ATCC. ... at ATCC described the additions as part of a ...
(Date:9/23/2014)... 2014  Age Defying Dermatology ® , owned and ... one of the first clinics in the Bay Area ... for tattoo removal. The treatment safely and effectively erases ... tattoo removal has been a lengthy, painful, and all ... an opportunity to erase tattoo pigment more efficiently with ...
(Date:9/23/2014)... , Sept. 23, 2014   GenoSpace , ... comprehensive suite of tools to enable the broad use ... announced that it has been awarded Phase I of ... from the National Institutes of Health (NIH) to enable ... Logo - http://photos.prnewswire.com/prnh/20140922/147649 ...
(Date:9/23/2014)... 2014 Healthcare professionals, patients ... convene at the Society for Integrative Oncology ... October 26-28 in Houston, Texas to discuss ... in individualized integrative cancer care. This multi-disciplinary ... nutritionists, naturopaths, acupuncturists, and other complementary care ...
Breaking Biology Technology:ATCC Announces New Appointments to its Leadership Team 2ATCC Announces New Appointments to its Leadership Team 3Age Defy Now Offers World's Most Advanced Technology for Tattoo Removal 2GenoSpace Awarded Fast Track SBIR Grant to Enable Data Access and Cohort Construction for Biorepositories 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 3
... Solution Supports Integration of Cardium Health, AirLogix, and Work/Life ... ... Company, BEDFORD, Mass., March 4 ... today,that Nurtur, a subsidiary of Centene Corporation (NYSE: CNC ), ...
... Progress at Seneca, Illinois ... Biodiesel Refinery, ... announced today that it has satisfied the conditions precedent,and completed its ... facility with WestLB AG, one of the world,s leading,financial services providers ...
... 2008 Lets eHarmony Forget About Storage and Focus on ... leading clustered NAS,systems provider, announces the launch of ExaStore ... needs in a full range of,applications and environments., ... storage,requirements, creating a considerable burden," says Dr. Arnon Gat, ...
Cached Biology Technology:Nurtur(TM) Selects CaseNET to Enable Integrated Health and Life Management Capabilities 2Nova Biosource Fuels Announces First Funding Under $41 Million Senior Secured Credit Facility 2Exanet Announces ExaStore 2008 Clustered NAS System 2
(Date:9/23/2014)... measure the effects of temperature on insects to predict ... but a Dartmouth study shows for the first time ... temperature, ultimately limits how fast they grow. , "In ... the overall environmental conditions that shape the growth, survival ... Lauren Culler , an Arctic postdoctoral researcher at ...
(Date:9/23/2014)... are fighting a cyberwar against cancer finds that the ... , "Recent research has found that cancer is already ... we studied the interplay between cancer and the immune ... on cancer," said Rice University,s Eshel Ben-Jacob, co-author of ... of the Proceedings of the National Academy of ...
(Date:9/23/2014)... Ill. Scientists have scoured cow rumens and termite ... cell walls for the production of next-generation biofuels, but ... in the human lower intestine, researchers report. , Their ... the National Academy of Sciences , is the first ... microbes in the human gut can digest fiber, breaking ...
Breaking Biology News(10 mins):Insects' fear limits boost from climate change, Dartmouth study shows 2Immune system is key ally in cyberwar against cancer 2Immune system is key ally in cyberwar against cancer 3Search for better biofuels microbes leads to the human gut 2Search for better biofuels microbes leads to the human gut 3
... N.C. -- Under a landmark agreement signed this week, ... an independent foundation at the Nicholas School of the ... new home, Duke Environment Hall. Research collaborations, ... legendary scientist E.O. Wilson are among the initiatives that ...
... turn parts of our genome off and on at strategic ... cells act and are impacted by environmental factors including diet, ... that aging also effects the epigenome in human skeletal muscle. ... provides a method to study sarcopenia, the degenerative loss ...
... of arsenic exposure regardless of arsenic concentrations in drinking and ... also confirms that toenail clippings are a good biomarker of ... dark meat fish. Exposure to arsenic has been linked to ... low birth weight. The findings appear in ...
Cached Biology News:E.O. Wilson Biodiversity Foundation moving to Duke 2Aging impacts epigenome in human skeletal muscle 2Dartmouth-led study shows diet alone can be significant source of arsenic 2